UNSPSC 51102908: Artesunate/mefloquine

Definition: This classification is for a combination antimalarial drug. The first component, ARTESUNATE, has a US FDA Unique Ingredient Identifier of 60W3249T9M. The second component, MEFLOQUINE, has a US FDA Unique Ingredient Identifier of TML814419R.

UNSPSC 51102908 Artesunate/mefloquine, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the code's nominal scope. The single relevant solicitation in the recent-opportunities block—Seminole County, Florida's IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—procures public-health pharmaceuticals but does not specifically name artesunate or mefloquine. The remaining opportunities tagged under this code span unrelated categories: a Collier County single-source award to Handtevy for EMS drug-dosage calculation software; Dane County's RFP for long-term-care facility pharmacy services; a District of Columbia pharmacy benefits network qualification request; West Texas Centers' RFP for prescription and pharmacy services across 23 counties; Tucson Fire Department's BLS/ALS pharmaceutical and vending-machine procurement; and Pinellas County's invitation to quote for certified drug-reference standards for forensic laboratory analysis. None of these solicitations reference antimalarial medications or the specific active ingredients this code nominally covers.

The code shows no recent state or local activity for artesunate or mefloquine procurement. Opportunities tagged under this UNSPSC are materially disconnected from the code's intended scope and instead reflect broader pharmacy, EMS pharmaceutical supply, and forensic reference-material procurement across Florida, Texas, Colorado, Wisconsin, and Oregon. Until state and local jurisdictions post solicitations explicitly for antimalarial pharmaceuticals, artesunate/mefloquine remains inactive under this taxonomy.